首页> 外国专利> New monoclonal immunoglobulin G3 antibodies (chimeric, humanized or human), useful for treating viral or bacterial infections or cancer, are produced in rat myeloma cell lines, potentiators of phagocytosis and inducers of cytokine release

New monoclonal immunoglobulin G3 antibodies (chimeric, humanized or human), useful for treating viral or bacterial infections or cancer, are produced in rat myeloma cell lines, potentiators of phagocytosis and inducers of cytokine release

机译:在大鼠骨髓瘤细胞系,吞噬作用增强剂和细胞因子释放诱导剂中产生了可用于治疗病毒或细菌感染或癌症的新型单克隆免疫球蛋白G3抗体(嵌合的,人源化的或人的)

摘要

Monoclonal, chimeric, humanized or human immunoglobulin G3 (IgG3) antibodies (Ab) produced in a rat myeloma cell line are new. Independent claims are also included for the following: (1) method for producing Ab; (2) rat myeloma cell lines (A) transfected with at least one vector that provides expression of functional IgG3; and (3) cells derived from (A). ACTIVITY : Virucide; Antibacterial; Cytostatic. No details of tests for these activities are given. MECHANISM OF ACTION : Induction of cytokine release from effector cells and potentiation of phagocytosis.
机译:在大鼠骨髓瘤细胞系中产生的单克隆,嵌合,人源化或人免疫球蛋白G3(IgG3)抗体(Ab)是新的。还包括以下方面的独立权利要求:(1)生产抗体的方法; (2)用至少一种提供功能性IgG3表达的载体转染的大鼠骨髓瘤细胞系(A); (3)来自(A)的细胞。活动:杀病毒剂;抗菌;止细胞的。没有提供这些活动的测试详细信息。作用机理:诱导效应细胞释放细胞因子并增强吞噬作用。

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号